Omeros (OMER) Receivables - Other (2011 - 2026)
Omeros recorded quarterly Receivables - Other of $92000.0 in Q1 2026, down 87.73% quarter-over-quarter from $750000.0 in Q4 2025, and down 93.65% year-over-year from $1.4 million in Q1 2025.
Omeros' Receivables - Other history runs 16 years deep, the most recent figure standing at $92000.0 for Q1 2026.
- In Q1 2026, Receivables - Other fell 93.65% year-over-year to $92000.0; the TTM figure through Mar 2026 stood at $92000.0 (down 93.65% YoY), while the FY2025 annual figure was $750000.0, down 6.13% from the prior year.
- Receivables - Other came in at $92000.0 for Q1 2026 at Omeros, down from $750000.0 in the prior quarter.
- In the past five years, Receivables - Other ranged from a high of $13.0 million in Q4 2022 to a low of $92000.0 in Q1 2026.
- A 5-year average of $2.5 million and a median of $810000.0 in 2022 frame the typical range for Receivables - Other.
- Across the five-year window, Receivables - Other surged 5388.71% in 2024 and plunged 93.65% in 2026, its largest moves.
- Omeros' Receivables - Other stood at $13.0 million in 2022, then slumped by 89.42% to $1.4 million in 2023, then slumped by 41.76% to $799000.0 in 2024, then declined by 6.13% to $750000.0 in 2025, then sank by 87.73% to $92000.0 in 2026.
- According to Business Quant data, Receivables - Other over the past three periods registered $92000.0, $750000.0, and $863000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Omeros | 772.03 Mn | 636.71 Mn | 9.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 92,000.00 |
| Mar 31, 2026 | 92,000.00 |
| Dec 31, 2025 | 750,000.00 |
| Dec 31, 2025 | 750,000.00 |
| Sep 30, 2025 | 863,000.00 |
| Sep 30, 2025 | 863,000.00 |
| Jun 30, 2025 | 1.07 Mn |
| Jun 30, 2025 | 1.07 Mn |
| Mar 31, 2025 | 1.45 Mn |
| Mar 31, 2025 | 1.45 Mn |
| Dec 31, 2024 | 799,000.00 |
| Dec 31, 2024 | 799,000.00 |
| Sep 30, 2024 | 6.10 Mn |
| Sep 30, 2024 | 6.10 Mn |
| Jun 30, 2024 | 6.81 Mn |
| Jun 30, 2024 | 6.81 Mn |
| Mar 31, 2024 | 656,000.00 |
| Mar 31, 2024 | 656,000.00 |
| Dec 31, 2023 | 1.37 Mn |
| Dec 31, 2023 | 1.37 Mn |
| Sep 30, 2023 | 6.66 Mn |
| Sep 30, 2023 | 6.66 Mn |
| Jun 30, 2023 | 124,000.00 |
| Jun 30, 2023 | 124,000.00 |
| Mar 31, 2023 | 302,000.00 |
| Mar 31, 2023 | 302,000.00 |
| Dec 31, 2022 | 12.97 Mn |
| Dec 31, 2022 | 12.97 Mn |
| Sep 30, 2022 | 741,000.00 |
| Sep 30, 2022 | 741,000.00 |
| Jun 30, 2022 | 810,000.00 |
| Jun 30, 2022 | 810,000.00 |
| Mar 31, 2022 | 408,000.00 |
| Mar 31, 2022 | 408,000.00 |
| Dec 31, 2021 | 1.65 Mn |
| Dec 31, 2021 | 1.65 Mn |
| Sep 30, 2021 | 274,000.00 |
| Sep 30, 2021 | 274,000.00 |
| Jun 30, 2021 | 420,000.00 |
| Jun 30, 2021 | 420,000.00 |
| Mar 31, 2021 | 250,000.00 |
| Mar 31, 2021 | 250,000.00 |
| Dec 31, 2020 | 70,000.00 |
| Dec 31, 2020 | 70,000.00 |
| Sep 30, 2020 | 161,000.00 |
| Sep 30, 2020 | 161,000.00 |
| Jun 30, 2020 | 86,000.00 |
| Jun 30, 2020 | 86,000.00 |
| Mar 31, 2020 | 106,000.00 |
| Mar 31, 2020 | 106,000.00 |
| Dec 31, 2019 | 111,000.00 |
| Dec 31, 2019 | 111,000.00 |
| Sep 30, 2019 | 122,000.00 |
| Sep 30, 2019 | 122,000.00 |
| Jun 30, 2019 | 134,000.00 |
| Jun 30, 2019 | 134,000.00 |
| Mar 31, 2019 | 138,000.00 |
| Mar 31, 2019 | 138,000.00 |
| Dec 31, 2018 | 164,000.00 |
| Dec 31, 2018 | 164,000.00 |
| Sep 30, 2018 | 132,000.00 |
| Sep 30, 2018 | 132,000.00 |
| Jun 30, 2018 | 29,000.00 |
| Jun 30, 2018 | 29,000.00 |
| Mar 31, 2018 | 133,000.00 |
| Mar 31, 2018 | 133,000.00 |
| Dec 31, 2017 | 65,000.00 |
| Dec 31, 2017 | 65,000.00 |
| Dec 31, 2016 | 100,000.00 |
| Dec 31, 2016 | 100,000.00 |
| Dec 31, 2015 | 136,000.00 |
| Dec 31, 2015 | 136,000.00 |
| Dec 31, 2014 | 324,000.00 |
| Dec 31, 2014 | 324,000.00 |
| Dec 31, 2013 | 71,000.00 |
| Dec 31, 2013 | 71,000.00 |
| Dec 31, 2012 | 1.49 Mn |
| Dec 31, 2012 | 1.49 Mn |
| Dec 31, 2011 | 14,000.00 |
| Dec 31, 2011 | 14,000.00 |